Kyowa Kirin Co (TSE:4151) Total Current Assets : 円581,362 Mil (As of Sep. 2023)

View and export this data going back to 1949. Start your Free Trial

What is Kyowa Kirin Co Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Kyowa Kirin Co's total current assets for the quarter that ended in Sep. 2023 was 円581,362 Mil.

Kyowa Kirin Co Total Current Assets Historical Data

The historical data trend for Kyowa Kirin Co's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyowa Kirin Co Total Current Assets Chart

Kyowa Kirin Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Current Assets

Get a 7-Day Free Trial

385,844.00

448,610.00

442,482.00

518,231.00

542,189.00

Kyowa Kirin Co Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Total Current Assets	Get a 7-Day Free Trial															522,378.00	542,189.00	528,582.00	574,065.00	581,362.00

Kyowa Kirin Co Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Kyowa Kirin Co's Total Current Assets for the fiscal year that ended in Dec. 2022 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	339720	+	111746	+	70675	+	20048
	=	542,189

Kyowa Kirin Co's Total Current Assets for the quarter that ended in Sep. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	383113	+	113621	+	71338	+	13290
	=	581,362

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Kyowa Kirin Co (TSE:4151) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Kyowa Kirin Co's Liquidation Value for the quarter that ended in Sep. 2023 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	383113	-	191908	+	0.75 * 113621	+	0.5 * 71338
=	312,090

Kyowa Kirin Co Total Current Assets Related Terms

Thank you for viewing the detailed overview of Kyowa Kirin Co's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Kyowa Kirin Co (TSE:4151) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kyowa Kirin Co Ltd (TSE:4151) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

KYKOY:USA KYKOF:USA

Address

1-9-2,Otemachi, Chiyoda-ku, Otemachi Financial City Grand Cube, Tokyo, JPN, 100-0004

Website

http://www.kyowa-kirin.com

Kyowa Kirin Co Ltd is a drug manufacturing company that focuses on biologic medicines. Its operations emphasize four categories: nephrology, oncology, immunology and allergy, and the central nervous system. The company has two reportable segments, Pharmaceuticals and Biochemicals. The pharmaceuticals business manufactures and sells ethical pharmaceuticals, diagnostic reagents, and other products. The biochemicals business manufactures and sells raw materials for pharmaceutical and industrial use, mainly amino acids, nucleic acids and related compounds, healthcare products, and others.

Kyowa Kirin Co (TSE:4151) Headlines

No Headlines